Yüksel Ürun: Key goals post ESMO24

Yüksel Ürun shared a post on LinkedIn:

“Key goals post ESMO24

1.Integrate findings into practice
2.Improve treatment accessibility
3.Update treatment guidelines
4.Educate clinicians and patients
5.Focus on long-term outcomes
6.Foster global collaboration.”

Giuseppe Curigliano shared this post adding:

“And impact on outcome of cancer patients.”

Source: Yüksel Ürun/LinkedIn and Giuseppe Curigliano/LinkedIn

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.

Giuseppe Curigliano, MD, PhD, is the Director of  the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues. He is the Editor-in-Chief of ESMO Open, the European Society for Medical Oncology’s open-access journal.